Form 4: Elanco Animal Health CFO Todd Young Reports Stock Transactions

Elanco Animal Health's CFO, Todd Young, reports acquisition and disposal of company stock and derivative securities, including stock options and restricted stock units.

Summary

• On March 1, 2024, Todd Young, CFO of Elanco Animal Health, was granted 43,903 restricted stock units under the 2018 Elanco Stock Plan.
• These units vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.
• On the same date, Young was also granted stock options for 95,749 shares, also vesting in three equal installments on the same dates.
• Young disposed of 14,000 shares on March 1, 2024, at a price of $16.03 to cover tax liabilities related to vesting restricted stock units.
• On March 5, 2024, Young transferred 37,999 directly owned shares to a living trust.
• Also on March 5, 2024, Young transferred 1,500 shares to himself as custodian for his daughter and 1,500 shares to himself as custodian for his son under the Uniform Gift to Minors Act.
• Following these transactions, Young directly owns 100,177 shares of Elanco stock.
• Young also indirectly owns shares through a living trust (149,308 shares), as UTMA custodian for his daughter (3,500 shares), as UTMA custodian for his son (3,500 shares), and through IRA accounts (6,562 shares in one IRA and 2,000 in another).

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and related to compensation and estate planning. The disposal of shares for tax purposes is a minor negative, but overall, the document doesn't convey strong positive or negative signals.

Positives

• The grant of restricted stock units and stock options to the CFO aligns his interests with those of the shareholders.
• The vesting schedule of the stock options and restricted stock units encourages long-term commitment from the CFO.

Negatives

• The disposal of 14,000 shares, even for tax purposes, could be perceived negatively by some investors.

Risks

• The vesting of a large number of shares over the next three years could create selling pressure if the CFO decides to sell the shares upon vesting.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting schedule of the stock options and restricted stock units suggests a continued commitment from the CFO for the next three years.

Industry Context

Insider transactions are common in publicly traded companies and are closely monitored by investors for signals about management's confidence in the company's future prospects. The grant of stock options and restricted stock units is a typical form of executive compensation in the animal health industry, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard compensation practices for executives in the animal health industry, similar to companies like Zoetis and Merck Animal Health.
• Vesting schedules of three years are also common, aligning with industry norms for long-term incentive plans.
• The size of the grant relative to the CFO's existing holdings and the company's market capitalization would be a relevant benchmark for comparison.

Related Party Transactions

• The transfers to the living trust and UTMA accounts are related-party transactions.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on stakeholders.

Key Dates